What is Xen Gel Stent?
The XEN gel stent is a minimally-invasive glaucoma surgery that makes significant reductions in intraocular pressure while decreasing the need for other medications. It was developed to provide long-term pressure-lowering benefits with much less surgical trauma to the eye. It also provides less risk of sight-threatening complications that are often associated with large pressure fluctuations after glaucoma surgery.
Minimally-invasive surgical approaches are revolutionizing the treatment of glaucoma. Less surgical trauma to the eye provides for safer intervention that may be done at earlier stages of the disease and allow for faster recovery than after traditional glaucoma surgery. In fact, most minimally-invasive procedures are designed to be performed on patients with mild to moderate glaucoma in the hopes of controlling this relentless disease and minimizing the burden of eye drops and other medications. However, the XEN gel stent is one of the few FDA-approved minimally-invasive options that can also be beneficially performed on patients with more advanced glaucoma, providing patients with even the most severe stages of glaucoma many of the same safety and recovery benefits afforded to those with less severe disease.
The XEN gel stent is also one of the few currently-available minimally-invasive treatments that can be performed as a standalone procedure, rather than having to be done at the same time as cataract surgery. Therefore, both patients with glaucoma who have already had cataract surgery or who still need cataract surgery may be eligible for this more effective but minimally-invasive option. In most cases, the XEN gel stent affords suitable patients with the opportunity to lower their eye pressure and get off many glaucoma medications.